Cargando…
Clinical Value of Asymmetrical Dimethylarginine Detection in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
OBJECTIVE: To evaluate the clinical value of serum asymmetrical dimethylarginine (ADMA) in patients with connective tissue disease- (CTD-) associated pulmonary arterial hypertension (PAH). METHODS: 88 patients with CTD were recruited between December 2017 and August 2018 in Jiangxi Provincial People...
Autores principales: | Liu, Juan, Fu, Qiang, Jiang, Lili, Wang, Youlian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710784/ https://www.ncbi.nlm.nih.gov/pubmed/31485349 http://dx.doi.org/10.1155/2019/3741909 |
Ejemplares similares
-
Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis
por: Segarra, Gloria, et al.
Publicado: (2016) -
Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude
por: Siques, Patricia, et al.
Publicado: (2019) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
por: Parmaksız, Elif Torun, et al.
Publicado: (2018) -
Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)